Bio-Rad Laboratories,
Inc. BIO and BIO, a multinational manufacturer and
distributor of life science research and clinical diagnostic
products, today announced that it has purchased AbD Serotec, a
division of MorphoSys AG, for approximately 53 million euros in cash.
AbD Serotec is one of the world's leading antibody manufacturers
offering over 15,000 antibodies, kits, and accessories. AbD Serotec
has an ISO 9001 and ISO 13485 certified production facility in the
United Kingdom, as well as other facilities in Germany and the U.S.
"We are pleased to have AbD Serotec join Bio-Rad," said Norman
Schwartz, Bio-Rad President and CEO. "With AbD Serotec's
comprehensive catalog of antibodies, we are able to offer our
customers total assay solutions that can be validated on many of our research platforms for western blotting, multiplex protein
expression, ELISA, and cell sorting."
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in